BCL2 and Familial prostate cancer: Although levels of BCL2 mRNA (a pro-survival gene) were not significantly affected by Par-4 overexpression in HT29 colon cancer cells, we included BCL2 in immunoblotting assays since Par-4 has been shown to regulate BCL2 mRNA in prostate cancer cell lines [35].